Eyal Rubin

Eyal Rubin

Finansdirektör/CFO på NASUS PHARMA LTD.
49 år
Health Technology
Consumer Services
Commercial Services

Profil

Eyal Rubin is Chief Financial Officer & Executive Vice President at Nasus Pharma Ltd. since 2025.
Former roles include CFO, Secretary, Treasurer & Senior Vice President at Protalix Biotherapeutics, Inc. from 2019 to 2025; Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2017 to 2019; Vice President & Head-Treasury at Teva Pharmaceutical Industries Ltd. from 2013 to 2017; Head-Finance & Banking Department at Cellcom Israel Ltd. from 2010 to 2013; Chief Financial Officer at Idt Carmel, Inc. from 2006 to 2010; Chief Financial Officer & General Manager at V-Secure Technologies, Inc. from 2003 to 2005; Chief Operating Officer & Vice President-Finance at Sec2Wireless, Inc. from 1999 to 2003.
Education includes an MBA from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.

Aktiva positioner av Eyal Rubin

FöretagPositionStart
NASUS PHARMA LTD. Finansdirektör/CFO 2025-11-20

Tidigare kända positioner av Eyal Rubin

FöretagPositionSlut
PROTALIX BIOTHERAPEUTICS, INC. Finansdirektör/CFO 2025-08-24
BRAINSTORM CELL THERAPEUTICS INC. Finansdirektör/CFO 2019-09-06
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Företagsledare/Principal 2017-01-01
CELLCOM ISRAEL LTD. Företagsledare/Principal 2013-03-01
Idt Carmel, Inc.
Finansdirektör/CFO 2010-01-01
Se detaljerna i Eyal Rubins erfarenhet

Eyal Rubins utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

68

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Commercial Services

Communications

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Idt Carmel, Inc.

Health Technology

  1. Börsen
  2. Insiders
  3. Eyal Rubin
40% rabatt: De bästa verktygen för prenumeranter för att identifiera morgondagens bästa investeringar!
d
:
:
TA DEL AV DET NU